05 Apr 22
10:32
10:32
Gamaleya's nasal Covid-19 vaccine well tolerated - developer
SHOW MORE >
02 Feb 22
19:03
19:03
Sputnik V manifested 70.5% efficacy against Delta variant half a year after vaccination - research
SHOW MORE >
10 Dec 21
10:39
10:39
EpiVacCorona vaccine to be efficacious against Omicron variant - developer
SHOW MORE >
13 Sep 21
11:32
11:32